COMMUNIQUÉS West-GlobeNewswire

International Endeavors Benefits from Legalization of Marijuana in Canada

21/06/2018 - 14:30

TEMECULA, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- International Endeavors Corp (OTC:IDVV) announces plans to work with the largest marijuana growers in Canada now that the Canadian government approved the legalization [...]

Imagin Engages Kilmer Lucas for Cross-Border Investor Relations

21/06/2018 - 14:30

VANCOUVER, British Columbia and BOSTON, June 21, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today announced that it has engaged [...]

Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018

21/06/2018 - 14:30

C3 Curriculum Designed for Physicians Specializing in Interventional Cardiology, Vascular Surgery and Interventional Radiology REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a [...]

GrowForce and Peguis First Nation announce cannabis joint venture

21/06/2018 - 14:14

First step in a Canada-wide expansion strategy with First Nations and Indigenous Peoples in the spirit of reconciliation and today’s National Aboriginal Day. WINNIPEG, Manitoba, June 21, 2018 (GLOBE NEWSWIRE) -- Today, [...]

ICC Labs Completes Its First Outdoor Harvest and Prepares to Produce Its First CBD Extracts

21/06/2018 - 14:09

VANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that it has completed its first outdoor harvest of hemp. The [...]

Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.

21/06/2018 - 14:00

New Role as the President involves leadership of the entire product portfolio Promotion reflects progress of Rigosertib to key data milestones NEWTOWN, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc [...]

ContraVir Pharmaceuticals Announces Data on Optimized Formulation of TXL™

21/06/2018 - 14:00

EDISON, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor

21/06/2018 - 14:00

Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in brain cancer PLYMOUTH MEETING, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: [...]

Cynata Reports Positive 28-day Data From Cohort B of Phase 1 Trial of CYP-001 in GvHD

21/06/2018 - 14:00

MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and efficacy data from a day 28 [...]

PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer

21/06/2018 - 14:00

Current PolarityTE CFO John Stetson will Become Chief Investment Officer of the Company and President of a New Strategic Arm—PolarityIS SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) [...]

Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia

21/06/2018 - 13:30

SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]

Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index

21/06/2018 - 13:30

Marinus’ addition to the indexes will be effective June 22, 2018, after market close RADNOR, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a [...]

Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients

21/06/2018 - 13:30

AUSTIN, Texas and RALEIGH, N.C., June 21, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Elligo Health Research , the only platform that [...]

Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market

21/06/2018 - 13:30

HOUSTON, June 21, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, all of [...]

Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly

21/06/2018 - 13:30

SAN DIEGO, June 21, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine [...]

The Joint Corp. CFO to Depart in July

21/06/2018 - 13:05

SCOTTSDALE, Ariz., June 21, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, reported CFO John Meloun will resign effective July 20, 2018. [...]

Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris® Test for Prostate Cancer

21/06/2018 - 13:05

Decision Follows Recently Updated Medical Guidelines for Prostate Cancer SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine [...]

Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinson’s Disease

21/06/2018 - 13:03

CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]

Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal

21/06/2018 - 13:00

CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]